By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, ...

Dr. Howard Forman reflects on heartening new evidence for the effectiveness of the HPV vaccine—and troubling signs of vaccine ...

Seven percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants.

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra Calabrese, DO, said during her presentation at Updates in Primary ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

Fewer than half of Americans believe federal health agencies like the Food and Drug Administration (FDA) and the Centers for ...

Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he's wasting no time charting a new course for the agency.

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

HealthDay News — The US Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced a new initiative called “Generation Gold Standard” to develop ...